slides · global inventory
Title
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 303,780
Current window 203,491-203,520
Pages 10,126
Rows per page 30
Component
203,491-203,520 of 303,780
12
SAD stands for Social Anxiety Disorder.Bionomics | Investor Presentation Deck | 59 slides · Bionomics
Pitch deck Investor relations 1 hit
15
The slide outlines a standard clinical decision-making process for pharmacotherapy.Bionomics | Investor Presentation Deck | 59 slides · Bionomics
Pitch deck Investor relations 1 hit
16
SAD likely refers to Social Anxiety Disorder. The image uses a metaphor of a single red figure facing a group of multi-colored figures.Bionomics | Investor Presentation Deck | 59 slides · Bionomics
Pitch deck Investor relations 1 hit
17
The slide illustrates the 'Approach' side of the conflict; the 'Avoidance' side is implied by the context of SAD.Bionomics | Investor Presentation Deck | 59 slides · Bionomics
Pitch deck Investor relations 1 hit
18
SAD likely stands for Social Anxiety Disorder. The diagram uses a circular flow to represent the internal conflict.Bionomics | Investor Presentation Deck | 59 slides · Bionomics
Pitch deck Investor relations 1 hit
19
Bionomics | Investor Presentation Deck | 59 slidesBionomics | Investor Presentation Deck | 59 slides · Bionomics
Pitch deck Investor relations 1 hit
20
Includes UC San Diego Health branding.Bionomics | Investor Presentation Deck | 59 slides · Bionomics
Pitch deck Investor relations Beat · Solution1 hit
21
Bionomics | Investor Presentation Deck | 59 slidesBionomics | Investor Presentation Deck | 59 slides · Bionomics
Pitch deck Investor relations Beat · Solution1 hit
23
Bionomics | Investor Presentation Deck | 59 slidesBionomics | Investor Presentation Deck | 59 slides · Bionomics
Pitch deck Investor relations Beat · Solution1 hit
24
The slide uses a circular crop for the image, which is a common design element in pitch decks to create visual interest.Bionomics | Investor Presentation Deck | 59 slides · Bionomics
Pitch deck Investor relations Beat · Solution1 hit
25
The slide uses a nested bulleted list to define the three core components of a behavioral challenge.Bionomics | Investor Presentation Deck | 59 slides · Bionomics
Pitch deck Investor relations Beat · Solution1 hit
26
Bionomics | Investor Presentation Deck | 59 slidesBionomics | Investor Presentation Deck | 59 slides · Bionomics
Pitch deck Investor relations Beat · Solution1 hit
27
BNC210 refers to the Trier Social Stress Test (TSST) or a variant thereof used in clinical research.Bionomics | Investor Presentation Deck | 59 slides · Bionomics
Pitch deck Investor relations Beat · Solution1 hit
28
The slide details the constraints of the experiment: 5 topics, 2 min prep, 5 min speech, and 3 audience members.Bionomics | Investor Presentation Deck | 59 slides · Bionomics
Pitch deck Investor relations Beat · Solution1 hit
29
This is a standard clinical measurement tool for anxiety and distress levels.Bionomics | Investor Presentation Deck | 59 slides · Bionomics
Pitch deck Investor relations 1 hit
30
The table maps specific time intervals (pre-dose, resting, preparation, performance, post-challenge) to data collection points.Bionomics | Investor Presentation Deck | 59 slides · Bionomics
Pitch deck Investor relations 1 hit
31
The table highlights the 'Public Speaking Challenge - Performance' phase with a purple border.Bionomics | Investor Presentation Deck | 59 slides · Bionomics
Pitch deck Investor relations 1 hit
32
The chart displays data from Bergamaschi et al. (2011) regarding acute CBD treatment for Social Anxiety Disorder (SAD).Bionomics | Investor Presentation Deck | 59 slides · Bionomics
Pitch deck Investor relations Beat · Traction1 hit
33
The chart highlights the efficacy of CBD in reducing anxiety during the 'A' (Anticipation) and 'S' (Speaking) phases of the challenge.Bionomics | Investor Presentation Deck | 59 slides · Bionomics
Pitch deck Investor relations Beat · Traction1 hit
34
The chart highlights a statistically significant difference between CBD and Placebo groups during the speaking phase.Bionomics | Investor Presentation Deck | 59 slides · Bionomics
Pitch deck Investor relations Beat · Traction1 hit
35
The chart highlights the performance phase where the PH94B group shows a downward trend in distress compared to the placebo group.Bionomics | Investor Presentation Deck | 59 slides · Bionomics
Pitch deck Investor relations Beat · Traction1 hit
36
The slide uses a hierarchical list to detail the research methodology.Bionomics | Investor Presentation Deck | 59 slides · Bionomics
Pitch deck Investor relations Beat · Traction1 hit
37
The chart highlights the 'Speech' phase with a box. SUDS is a standard clinical measure for anxiety.Bionomics | Investor Presentation Deck | 59 slides · Bionomics
Pitch deck Investor relations Beat · Traction1 hit
38
Bionomics | Investor Presentation Deck | 59 slidesBionomics | Investor Presentation Deck | 59 slides · Bionomics
Pitch deck Investor relations 1 hit
40
The slide uses a list-based layout with icons to summarize key company highlights.Bionomics | Investor Presentation Deck | 59 slides · Bionomics
Pitch deck Investor relations Loop · Pareto Focus1 hit
41
Includes a legend for FDA Fast Track designation and definitions for NAM/PAM.Bionomics | Investor Presentation Deck | 59 slides · Bionomics
Pitch deck Investor relations Loop · Pareto Focus1 hit
42
Includes a detailed biological process diagram and a conceptual model of disease state vs. normalized state.Bionomics | Investor Presentation Deck | 59 slides · Bionomics
Pitch deck Investor relations 1 hit
43
The table lists 13 rows, though the title mentions 12 trials; likely one trial is split or there is a discrepancy in the count.Bionomics | Investor Presentation Deck | 59 slides · Bionomics
Pitch deck Investor relations 1 hit
44
The table uses checkmarks and X marks to denote presence or absence of specific clinical benefits/side effects.Bionomics | Investor Presentation Deck | 59 slides · Bionomics
Pitch deck Investor relations 1 hit
47
The slide uses a bar chart to compare placebo vs BNC210 across two metrics: total number of symptoms and symptom intensity.Bionomics | Investor Presentation Deck | 59 slides · Bionomics
Pitch deck Investor relations 1 hit